Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion

Nucleic Acids Research

Volumn 41, Issue 9, 2013, Pages 4949-4962

  Liu, Yuying ^a   Conaway, Lashardai ^a   Rutherford Bethard, Jennifer ^a   Al Ayoubi, Adnan M ^a   Thompson Bradley, Amber ^a   Zheng, Hui ^a   Weed, Scott A ^b   Eblen, Scott T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 1 LIKE KINASE 1; FAS ANTIGEN; FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; REGULATOR PROTEIN; SERINE; SPLICING FACTOR 45; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXON; GENETIC TRANSFECTION; MUTANT; OVARY CANCER; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA BINDING;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD95; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CORTACTIN; EXONS; FIBRONECTINS; HUMANS; MUTATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA SPLICE SITES; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84877287737     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt170     Document Type: Article

References (55)

1. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. and Blencowe, B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
2. Wang, G.S. and Cooper, T.A. (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet., 8, 749-761.
3. Matlin, A.J., Clark, F. and Smith, C.W. (2005) Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol., 6, 386-398.
4. Skotheim, R.I. and Nees, M. (2007) Alternative splicing in cancer: noise, functional, or systematic? Int. J. Biochem. Cell Biol., 39, 1432-1449.
5. Rino, J. and Carmo-Fonseca, M. (2009) The spliceosome: a self-organized macromolecular machine in the nucleus? Trends Cell Biol., 19, 375-384.
6. Mayeda, A. and Krainer, A.R. (1992) Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell, 68, 365-375.
7. Caputi, M., Mayeda, A., Krainer, A.R. and Zahler, A.M. (1999) hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J., 18, 4060-4067.
8. Rothrock, C.R., House, A.E. and Lynch, K.W. (2005) HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J., 24, 2792-2802.
9. Expert-Bezancon, A., Sureau, A., Durosay, P., Salesse, R., Groeneveld, H., Lecaer, J.P. and Marie, J. (2004) hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B. J. Biol. Chem., 279, 38249-38259.
10. Shepard, P.J. and Hertel, K.J. (2009) The SR protein family. Genome Biol., 10, 242.
11. Hanamura, A., Caceres, J.F., Mayeda, A., Franza, B.R. Jr and Krainer, A.R. (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA, 4, 430-444.
12. Grosso, A.R., Martins, S. and Carmo-Fonseca, M. (2008) The emerging role of splicing factors in cancer. EMBO Rep., 9, 1087-1093.
13. Grosso, A.R., Gomes, A.Q., Barbosa-Morais, N.L., Caldeira, S., Thorne, N.P., Grech, G., von Lindern, M. and Carmo-Fonseca, M. (2008) Tissue-specific splicing factor gene expression signatures. Nucleic Acids Res., 36, 4823-4832.
14. Izquierdo, J.M., Majos, N., Bonnal, S., Martinez, C., Castelo, R., Guigo, R., Bilbao, D. and Valcarcel, J. (2005) Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell, 19, 475-484.
15. Stamm, S. (2008) Regulation of alternative splicing by reversible protein phosphorylation. J. Biol. Chem., 283, 1223-1227.
16. Xiao, S.H. and Manley, J.L. (1997) Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev., 11, 334-344.
17. Shin, C., Feng, Y. and Manley, J.L. (2004) Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature, 427, 553-558.
18. Ma, C.T., Ghosh, G., Fu, X.D. and Adams, J.A. (2010) Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1. J. Mol. Biol., 403, 386-404.
19. Duncan, P.I., Stojdl, D.F., Marius, R.M. and Bell, J.C. (1997) In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol. Cell. Biol., 17, 5996-6001.
20. Duncan, P.I., Stojdl, D.F., Marius, R.M., Scheit, K.H. and Bell, J.C. (1998) The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing. Exp. Cell Res., 241, 300-308.
21. Al-Ayoubi, A.M., Zheng, H., Liu, Y., Bai, T. and Eblen, S.T. (2012) Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion. Mol. Cell. Biol., 32, 2880-2893.
22. Colwill, K., Pawson, T., Andrews, B., Prasad, J., Manley, J.L., Bell, J.C. and Duncan, P.I. (1996) The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J., 15, 265-275.
23. Misteli, T., Caceres, J.F., Clement, J.Q., Krainer, A.R., Wilkinson, M.F. and Spector, D.L. (1998) Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell Biol., 143, 297-307.
24. Yomoda, J., Muraki, M., Kataoka, N., Hosoya, T., Suzuki, M., Hagiwara, M. and Kimura, H. (2008) Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A. Genes Cells, 13, 233-244.
25. Mermoud, J.E., Cohen, P. and Lamond, A.I. (1992) Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Res., 20, 5263-5269.
26. Tazi, J., Daugeron, M.C., Cathala, G., Brunel, C. and Jeanteur, P. (1992) Adenosine phosphorothioates (ATP alpha S and ATP tau S) differentially affect the two steps of mammalian pre-mRNA splicing. J. Biol. Chem., 267, 4322-4326.
27. Cao, W., Jamison, S.F. and Garcia-Blanco, M.A. (1997) Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA, 3, 1456-1467.
28. Neubauer, G., King, A., Rappsilber, J., Calvio, C., Watson, M., Ajuh, P., Sleeman, J., Lamond, A. and Mann, M. (1998) Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet., 20, 46-50.
29. Aravind, L. and Koonin, E.V. (1999) G-patch: a new conserved domain in eukaryotic RNA-processing proteins and type D retroviral polyproteins. Trends Biochem. Sci., 24, 342-344.
30. Silverman, E.J., Maeda, A., Wei, J., Smith, P., Beggs, J.D. and Lin, R.J. (2004) Interaction between a G-patch protein and a spliceosomal DEXD/H-box ATPase that is critical for splicing. Mol. Cell. Biol., 24, 10101-10110.
31. Callebaut, I., Wecker, K., Prochnicka-Chalufour, A., Dendouga, N., Zinn-Justin, S., Delepierre, M., Tomavo, S. and Wolff, N. (2006) Structural and functional characterization of the TgDRE multidomain protein, a DNA repair enzyme from Toxoplasma gondii. Biochemistry, 45, 4867-4874.
32. Svec, M., Bauerova, H., Pichova, I., Konvalinka, J. and Strisovsky, K. (2004) Proteinases of betaretroviruses bind single-stranded nucleic acids through a novel interaction module, the G-patch. FEBS Lett., 576, 271-276.
33. Corsini, L., Bonna, S., Basquin, J., Hothorn, M., Scheffzek, K., Valcarcel, J. and Sattler, M. (2007) U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat. Struct. Mol. Biol., 14, 620-629.
34. Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J. and Mountz, J.D. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 263, 1759-1762.
35. Sampath, J., Long, P.R., Shepard, R.L., Xia, X., Devanarayan, V., Sandusky, G.E., Perry, W.L. 3rd, Dantzig, A.H., Williamson, M., Rolfe, M. et al. (2003) Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells. Am. J. Pathol., 163, 1781-1790.
36. Perry, W.L. 3rd, Shepard, R.L., Sampath, J., Yaden, B., Chin, W.W., Iversen, P.W., Jin, S., Lesoon, A., O'Brien, K.A., Peek, V.L. et al. (2005) Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed-a phenotype partially reversed by selective estrogen receptor modulators. Cancer Res., 65, 6593-6600.
37. Eblen, S.T., Catling, A.D., Assanah, M.C. and Weber, M.J. (2001) Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2. Mol. Cell. Biol., 21, 249-259.
38. Wu, H., Reynolds, A.B., Kanner, S.B., Vines, R.R. and Parsons, J.T. (1991) Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. Cell. Biol., 11, 5113-5124.
39. Kelley, L.C., Hayes, K.E., Ammer, A.G., Martin, K.H. and Weed, S.A. (2010) Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS One, 5, e13847.
40. Talwar, S., Jin, J., Carroll, B., Liu, A., Gillespie, M.B. and Palanisamy, V. (2011) Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress. J. Biol. Chem., 286, 32333-32343.
41. Muraki, M., Ohkawara, B., Hosoya, T., Onogi, H., Koizumi, J., Koizumi, T., Sumi, K., Yomoda, J., Murray, M.V., Kimura, H. et al. (2004) Manipulation of alternative splicing by a newly developed inhibitor of Clks. J. Biol. Chem., 279, 24246-24254.
42. Lallena, M.J., Chalmers, K.J., Llamazares, S., Lamond, A.I. and Valcarcel, J. (2002) Splicing regulation at the second catalytic step by Sex-lethal involves 3' splice site recognition by SPF45. Cell, 109, 285-296.
43. Zou, L., Cao, S., Kang, N., Huebert, R.C. and Shah, V.H. (2012) Fibronectin induces endothelial cell migration through beta1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766. J. Biol. Chem., 287, 7190-7202.
44. Mitra, A.K., Sawada, K., Tiwari, P., Mui, K., Gwin, K. and Lengyel, E. (2011) Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene, 30, 1566-1576.
45. Caswell, P.T., Spence, H.J., Parsons, M., White, D.P., Clark, K., Cheng, K.W., Mills, G.B., Humphries, M.J., Messent, A.J., Anderson, K.I. et al. (2007) Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev. Cell, 13, 496-510.
46. Nishida, T., Nakagawa, S., Awata, T., Ohashi, Y., Watanabe, K. and Manabe, R. (1983) Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J. Cell Biol., 97, 1653-1657.
47. Kirkbride, K.C., Sung, B.H., Sinha, S. and Weaver, A.M. (2011) Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adh. Migr., 5, 187-198.
48. van Rossum, A.G., de Graaf, J.H., Schuuring-Scholtes, E., Kluin, P.M., Fan, Y.X., Zhan, X., Moolenaar, W.H. and Schuuring, E. (2003) Alternative splicing of the actin binding domain of human cortactin affects cell migration. J. Biol. Chem., 278, 45672-45679.
49. Campbell, D.H., Sutherland, R.L. and Daly, R.J. (1999) Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res., 59, 5376-5385.
50. Martinez-Quiles, N., Ho, H.Y., Kirschner, M.W., Ramesh, N. and Geha, R.S. (2004) Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol. Cell. Biol., 24, 5269-5280.
51. Colwill, K., Feng, L.L., Yeakley, J.M., Gish, G.D., Caceres, J.F., Pawson, T. and Fu, X.D. (1996) SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. J. Biol. Chem., 271, 24569-24575.
52. Menegay, H.J., Myers, M.P., Moeslein, F.M. and Landreth, G.E. (2000) Biochemical characterization and localization of the dual specificity kinase CLK1. J. Cell Sci., 113(Pt.18), 3241-3253.
53. Lai, M.C., Kuo, H.W., Chang, W.C. and Tarn, W.Y. (2003) A novel splicing regulator shares a nuclear import pathway with SR proteins. EMBO J., 22, 1359-1369.
54. Huang, Y., Yario, T.A. and Steitz, J.A. (2004) A molecular link between SR protein dephosphorylation and mRNA export. Proc. Natl Acad. Sci. USA, 101, 9666-9670.
55. MacGrath, S.M. and Koleske, A.J. (2012) Cortactin in cell migration and cancer at a glance. J. Cell Sci., 125, 1621-1626.